Croma-Pharma GmbH:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Croma-Pharma GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10936
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストリア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Croma-Pharma GmbH (Croma Pharma) is a pharmaceutical company that offers development and commercialization of drugs in the field of aesthetic dermatology. The company’s products include princess skincare, princess injectables, and princess lift products. Its princess skincare products comprise princess skincare masks and princess skincare serums. Croma Pharma’s princess lift products include happy lift and PDO. The company distributes its products in countries through its own commercial sales organization and through strategic partnerships and distributors. It has its operations in Canada, Germany, Austria, Belgium, Brazil, Poland, Romania, France, the Netherlands, Spain, and the US. Croma Pharma is headquartered in Leobendorf, Austria.

Croma-Pharma GmbH – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Croma-Pharma GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Croma-Pharma GmbH, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Croma-Pharma GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Croma-Pharma GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Croma-Pharma GmbH, Medical Devices Deals, 2012 to YTD 2018 9
Croma-Pharma GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Croma-Pharma GmbH, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Croma-Pharma Forms Joint Venture with Hugel 11
Croma Pharma Enters Into Distribution Agreement With Hugel 12
Licensing Agreements 13
Croma-Pharma Enters into Licensing Agreement with Universkin 13
Asset Transactions 14
Valeant Pharma Acquires Medical Devices And Food Supplements Assets Of Croma-Pharma 14
Croma-Pharma GmbH – Key Competitors 15
Croma-Pharma GmbH – Key Employees 16
Croma-Pharma GmbH – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Strategy And Business Planning 18
Feb 01, 2017: CROMA-PHARMA opens 12th subsidiary in Germany 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Croma-Pharma GmbH, Pharmaceuticals & Healthcare, Key Facts 2
Croma-Pharma GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Croma-Pharma GmbH, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Croma-Pharma GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Croma-Pharma GmbH, Deals By Therapy Area, 2012 to YTD 2018 8
Croma-Pharma GmbH, Medical Devices Deals, 2012 to YTD 2018 9
Croma-Pharma GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Croma-Pharma Forms Joint Venture with Hugel 11
Croma Pharma Enters Into Distribution Agreement With Hugel 12
Croma-Pharma Enters into Licensing Agreement with Universkin 13
Valeant Pharma Acquires Medical Devices And Food Supplements Assets Of Croma-Pharma 14
Croma-Pharma GmbH, Key Competitors 15
Croma-Pharma GmbH, Key Employees 16
Croma-Pharma GmbH, Subsidiaries 17

List of Figures
Croma-Pharma GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Croma-Pharma GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Croma-Pharma GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Croma-Pharma GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Croma-Pharma GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Croma-Pharma GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Croma-Pharma GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Croma-Pharma GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Croma-Pharma GmbH, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Croma-Pharma GmbH:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • SuperGroup Plcの企業概要及び財務/SWOT分析
    SuperGroup Plc Fundamental Company Report provides a complete overview of the company’s affairs. The report includes financial and SWOT information, industry analysis, opinions, estimates, SuperGroup Plc annual and quarterly forecasts made by stock market experts. The report also enables direct comp …
  • Stanbic IBTC Holdings PLC (STANBIC):企業概要およびSWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "Stanbic IBTC Holdings PLC" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Timetric strictly …
  • Kolltan Pharmaceuticals, Inc.:企業のM&A・提携・投資分析
    Kolltan Pharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Kolltan Pharmaceuticals, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • Phosphagenics Ltd:企業の戦略・SWOT・財務情報
    Phosphagenics Ltd - Strategy, SWOT and Corporate Finance Report Summary Phosphagenics Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Eni SpA (ENI):石油・ガス:M&Aディール及び事業提携情報
    Summary Eni SpA (Eni) is an integrated oil and gas company that carries out oil and natural gas exploration, field development and production activities. It is also involved in supply, trading and shipping of natural gas, LNG, electricity and fuels. The company has operations in Italy, Cyprus, the U …
  • Bengal Energy Ltd. (BNG):企業財務及び戦略的SWOT分析
    Summary Bengal Energy Ltd. (Bengal Energy), formerly Avery Resources Inc. is an oil and gas company that offers exploration services. The company explores, acquires and produces oil and natural gas assets producing light oil-weighted onshore assets. Its onshore assets are located in Australia’s Coop …
  • Hanesbrands Inc.:企業の戦略・SWOT・財務情報
    Hanesbrands Inc. - Strategy, SWOT and Corporate Finance Report Summary Hanesbrands Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Convio, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Convio, Inc. Mergers and Acquis …
  • Dunnes Stores:企業の戦略・SWOT・財務分析
    SummaryDunnes Stores - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findings …
  • GenVec, Inc.:企業のM&A・提携・投資分析
    GenVec, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's GenVec, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • Manipal Hospital:企業のM&A・提携動向(医療分野)
    Summary Manipal Hospital, formerly Manipal Health Systems is a healthcare service provider that provides primary, secondary and tertiary healthcare services. The hospital provides services such as robotic assisted surgery, eye care, rehabilitation, skin care, accident and emergency care, child care, …
  • Astute Medical Inc-医療機器分野:企業M&A・提携分析
    Summary Astute Medical Inc (Astute Medical) is a healthcare service provider that provides diagnostic products. The company offers biomarker products such as nephro check test and astute meter. Its products are used in the field of identifying and validating biomarkers of acute kidney injury through …
  • Bend Research Inc.(製薬・医療分野):企業M&A動向
    Summary Bend Research Inc. (Bend Research) is a biotechnology company which provides drug delivery technologies and formulation development. The company has expertise in formulation science, dosage form development, process development, engineering, cGMP manufacturing, bioprocessing and biotherapeut …
  • Gilson, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Gilson, Inc. Mergers and Acquis …
  • HTC Corporation:企業の戦略・SWOT・財務分析
    SummaryHTC Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Finding …
  • Usinas Siderurgicas de Minas Gerais S.A.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Usinas Siderurgicas de Minas Ge …
  • Joincare Pharmaceutical Group Industry Co., Ltd. (600380):企業概要、財務及び戦略的SWOT分析
    Summary Joincare Pharmaceutical Group Industry Co., Ltd. (Joincare) is a pharmaceutical company. The company manufactures and markets pharmaceutical and cosmetics products. It offers health care products, taitai pharmaceutical, health pharmaceutical, hiyeah industry, BPC, prescription medicine, OTC, …
  • OpGen Inc (OPGN)-医療機器分野:企業M&A・提携分析
    Summary OpGen Inc (OpGen) is a molecular diagnostics company that harnesses genomic analysis and bioinformatics to prevent the threat of antibiotic resistance and multi drug resistant organisms (MDROs). The company’s clinical laboratory services include high resolution microbial sequence analysis, s …
  • Actelion Ltd:企業の戦略・SWOT・財務分析
    SummaryActelion Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findings - …
  • Boubyan Petrochemical Company KSC:企業の戦略・SWOT・財務分析
    SummaryBoubyan Petrochemical Company KSC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the co …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆